News
Moderna's New Lower-Dose COVID-19 Vaccine Approved by FDA
By Stephanie Brown HealthDay ReporterTUESDAY, June 3, 2025 (HealthDay News) -- The U.S. Food and Drug Administration has approved a new lower-dose vaccine for active immunization against COVID-19 caused by severe acute respiratory syndrome coronavirus 2.
Moderna's new COVID-19 vaccine mNexspike approved by FDA, but there's a limit on who can use it
The FDA's approval was based on a study of 11,400 people age 12 and older that compared the new low-dose vaccine with Moderna's existing vaccine. It found the new vaccine was safe and was at least as effective - and more by some measures - than the original shot, the company said.
The biotech’s mRNA vaccines were lauded by the first Trump administration but now are caught up in government changes to ...
Moderna’s newest lower-dose COVID-19 vaccine is approved for all adults 65 and older, and for people aged 12 to 64 who are at ...
Moderna (NASDAQ: MRNA) stock represented the ticket to an investing win. The company brought its coronavirus vaccine from ...
The Centers for Disease Control and Prevention says children without underlying health conditions "may receive" a COVID-19 ...
What to Expect on MSN5d
Should Pregnant Women Still Get the COVID-19 Vaccine?You may be debating whether or not you should get the COVID-19 vaccine during pregnancy, especially since there are conflicting guidelines, messages, and stories about whether or not it's recommended ...
THURSDAY, May 29, 2025 (HealthDay News) — The U.S. government has canceled a $600 million contract with Moderna to develop a ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback